Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia

Emerg Infect Dis. 2022 Feb;28(2):463-465. doi: 10.3201/eid2802.211640.


Population-based data on coronavirus disease in Russia and on the immunogenicity of the Sputnik V vaccine are sparse. In a survey of 1,080 residents of Arkhangelsk 40-75 years of age, 65% were seropositive for IgG. Fifteen percent of participants had been vaccinated; of those, 97% were seropositive.

Keywords: Arkhangelsk; Belova N; COVID-19; Kudryavtsev A; Postoev V; Russia; Russia. Emerg Infect Dis. 2022 Feb [date cited].; SARS-CoV-2; Shagrov L; Sharashova E; Suggested citation for this article: Krieger E; antibodies; epidemiology; et al. Seroprevalence of SARS-CoV-2 antibodies in adults; respiratory infections; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Viral
  • COVID-19*
  • Humans
  • Russia / epidemiology
  • SARS-CoV-2*
  • Seroepidemiologic Studies


  • Antibodies, Viral